Jeffrey M. Brown

Radiology
704 Hebron Ave Ste 100
Glastonbury, CT 06033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.

Journal: Molecular therapy. Nucleic acids
Published: October 20, 2021

Investigational Assay for Haplotype Phasing of the Huntingtin Gene.

Investigational Assay for Haplotype Phasing of the Huntingtin Gene.

Journal: Molecular therapy. Methods & clinical development
Published: March 13, 2020

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA.

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA.

Journal: RNA biology
Published: March 27, 2018

Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery.

Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery.

Journal: BMC research notes
Published: January 13, 2018

Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6.

Optimized Mitochondrial Targeting of Proteins Encoded by Modified mRNAs Rescues Cells Harboring Mutations in mtATP6.

Journal: Cell reports
Published: November 07, 2017

Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway.

Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway.

Journal: Lancet (London, England)
Published: August 28, 2015
Showing 1-6 of 6

Last Updated: 09/26/2026